An increase in red cell mass is the primary feature of polycythemia vera (PV) [4] [8] [10]. Bone marrow analysis, however, shows a proliferation of all three myeloid lines: erythrocytes, granulocytes and platelets. The onset of polycythemia vera is often insidious. Early symptoms are related to blood hyperviscosity due to polycythemia. Decreased blood flow and thrombosis result in hypoxia [8] [10] [11]. Patients often present with either arterial or venous vascular occlusive events [10].

Presenting non-specific symptoms of polycythemia vera are related to hypoxia and include [10]:

• Headache
• Dizziness
• Visual impairment
• Tinnitus
• Angina pectoris

The signs and symptoms found in individuals diagnosed with polycythemia vera include [9] [10]:

• Elevated red blood cell mass >25%
• Erythrocytosis, hematocrit >60 males, >56 females
• Leukocytosis >10.9/ml
• Thrombocytosis, platelet count >400,000/ml
• Splenomegaly and splenic infract
• Thrombotic and hemorrhagic complications
• Vasomotor disturbances
• Pruritus
• Elevated Vitamin B12 level
• Plethora, a ruddy complexion of face, palms, nail beds, mucosa, and conjunctiva, due to the increased total red blood cell count.

Thrombosis and bleeding are frequent in persons with polycythemia vera. These complications are the result of the increased red blood cell count and elevated platelet count [9] [10] [19]. Bleeding is seen in approximately 1% of patients, epistaxis, gum bleeding, ecchymoses, and gastrointestinal (GI) bleeding [8] [10]. Peptic ulcer disease occurs with polycythemia vera due to increased histamine levels and resulting gastric acidity. This causes abdominal pain, abnormal feeling of fullness, and anorexia. Weight loss may result [9].

Erythromelalgia is a syndrome specific to polycythemia vera. It increases the risk of thrombosis. The symptoms are burning pain in the feet, hands, toes and fingers, sometimes associated with pallor, erythema, or cyanosis. Occasionally, it progresses to gangrene. This can be treated with aspirin (50-300 mg/d) and dipyridamole (75 mg orally 3 times a day) [11] [15].

Pruritus also results from increased histamine levels due to increased basophils and mast cells. This occurs in up to 40% of patients with polycythemia vera [9]. Splenomegaly is present in 75% of patients at the time of diagnosis, hepatomegaly in approximately 30% of patients [10] [16].

• Easy Bruising

  Some patients with PV will not demonstrate any symptoms at all, but many will experience easy bruising or bleeding with little or no injury. Also, the blood may be thick and gummy, causing it to clot in tiny blood vessels. [uihc.org]

  Case 2 25 years old, male patient was referred to hematology clinic with complaints of weakness, headache, itching and easy bruising on areas open for trauma. Patient had no history of chronic diseases, drug using and smoking. [oatext.com]

  Individuals, who demonstrate signs and symptoms, have the following: Trouble breathing, feeling weak and tired Easy bruising and bleeding Severe, throbbing headache Skin appears red, or skin color changes due to lack of oxygen (blue) Visual problems, [dovemed.com]

  PV or blood thinners used to manage it can increase your risk for heavy bleeding and easy bruising. Use an electric razor and soft toothbrush. Floss your teeth gently. Do not play contact sports, such as football. [drugs.com]

• Pain

  This case provides additional evidence to the data for HBO2 use in ischemic pain management. [ncbi.nlm.nih.gov]

  […] walking, pain relief with resting and reproduce with walking in a same distance. [medicaljoyworks.com]

  Blood clots in the liver and spleen can cause sudden, intense pain. Slowed blood flow also prevents enough oxygen-rich blood from reaching your organs. This can lead to angina (chest pain or discomfort) and heart failure. [hoacny.com]

• Fatigue

  Regardless of baseline iron status, treatment with ruxolitinib was associated with improvements in concentration problems, cognitive function, dizziness, fatigue, headaches, and inactivity, although improvements were generally greater among patients with [ncbi.nlm.nih.gov]

  Chronic Fatigue Syndrome or Fibromyalgia Just like the name implies, chronic fatigue syndrome just might be the source of your constant exhaustion, says sleep specialist Dr. Arthur N. Falk. Or it could be fibromyalgia. [livestrong.com]

  Moreover, he has felt chronically fatigued and has lost 10 pounds without dieting or changing his appetite. He currently takes metformin and his most recent hemoglobin A1c was 6.5%. [step1.medbullets.com]

• Weakness

  tingling, burning or weakness in your hands, feet, arms or legs A feeling of fullness or bloating in your left upper abdomen due to an enlarged spleen Fevers Unexplained weight loss When to see a doctor Make an appointment with your doctor if you have [mayoclinic.org]

  Weak recommendations use "consider" or "suggested" phrasing. Recommendations are explicitly labeled as Strong recommendations or Weak recommendations when a qualified group has explicitly deliberated on making such a recommendation. [dynamed.com]

  However, some people may experience: Itchiness, especially following a warm bath or shower Headache Dizziness Weakness Excessive sweating Painful swelling of one joint, often the big toe Shortness of breath Breathing difficulty when you lie down Numbness [checkorphan.org]

  Headaches Double vision or seeing dark or blind spots that come and go Itching all over the body, especially after being in warm or hot water Reddened face that looks like a blush or sunburn Weakness Dizziness Weight loss for no known reason [seattlecca.org]

  When left untreated, these headaches can intensify, leading to dizziness, lightheadedness, and overall feelings of weakness. If these feelings become a part of your daily routine, be sure to talk to your doctor. ADVERTISEMENT [activebeat.com]

• Weight Loss

  Palpable splenomegaly is one of the worst offenders since it contributes to early satiety, bloating, pain, portal hypertension, weight loss, and exacerbation of cytopenia. [medpagetoday.com]

  This is especially true for cytokine-driven items (night sweats, bone pain, weight loss) and abdominal-related complaints (abdominal discomfort, weight loss) in patients in the PV-HU subgroup. [jco.ascopubs.org]

  Hydroxycarbamide If your platelet count is high or you have other symptoms such as weight loss or sweats, you may be given tablets called hydroxycarbamide (or hydroxyurea) to take. [bloodwise.org.uk]

  Headaches Double vision or seeing dark or blind spots that come and go Itching all over the body, especially after being in warm or hot water Reddened face that looks like a blush or sunburn Weakness Dizziness Weight loss for no known reason [seattlecca.org]

  loss in 6 months Night sweats Unexplained fever Dita Gratzinger MD PhD Tracy I George MD Department of Pathology Stanford University School of Medicine Stanford CA 94305-5342 Original posting: 10/23/11 [surgpathcriteria.stanford.edu]

• Plethora

  PV is also associated with a plethora of symptoms that are poorly controlled by conventional therapy. This article summarizes my approach to the management of PV in daily clinical practice. [ncbi.nlm.nih.gov]

  Physical examination reveals plethora and engorged retinal veins. The spleen is palpable in 75% of cases but is nearly always enlarged when imaged. [accessmedicine.mhmedical.com]

  /erythema -67%, Conjunctival plethora-59%, Engorged vessels in the optic fluid- 46%, Systolic BP 140 mm Hg- 72%, Diastolic BP 90 mm Hg- 32% CAUSES : unknown DIFFERENTIAL DIAGNOSIS Secondary polycythemias Hemoglobinopathy Spurious polycythemia LABORATORY [enotes.tripod.com]

  Constitutional symptoms: weight loss, fatigue, sweating Hyperviscosity syndrome (triad of mucosal bleeding, neurological symptoms, and visual changes) Plethora Facial flushing Cyanotic lips Pruritus: Itching typically worsens when the skin comes into [amboss.com]

  Help me code for diagnosis year : Alternate Names Acquired true primary polycythemia Cryptogenic polycythemia Erythremia Erythrocytosis megalosplenica Masked polycythemia Myelopathic polycythemia Osler-Vaquez disease Plethora vera Polycythemia rubra vera [seer.cancer.gov]

• Splenomegaly

  During multivariable analysis, leukocytosis 15 10 9 /l, palpable splenomegaly and grade 1 BM reticulin fibrosis remained significant. [ncbi.nlm.nih.gov]

  Patients should be followed monthly until normalization of blood cell counts and splenomegaly, then every 2 months for complete blood count and blood smear evaluation. [symptoma.com]

  In time myelofibrosis occurs Myeloproliferative disorder characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume; associated frequently with splenomegaly, leukocytosis [icd9data.com]

• Palpable Spleen

  A 50% palpable spleen length reduction was observed at any time during therapy in 20/32 evaluable patients. [ncbi.nlm.nih.gov]

  Polycythemia Vera Signs and symptoms Symptoms related to expanded blood volume and increased viscosity Headache, tinnitus, dizziness, blurred vision, TIAs, and fatigue Generalized pruritus (aquagenic) Engorged retinal veins Palpable spleen (75%) Thrombosis [slideshare.net]

  spleen N (%) 16 (55) 14 (42) 0.316 Cardiovascular risk factors N (%) 16 (53) 20 (57) 0.758 Previous thrombosis N (%) 5 (17) 9 (26) 0.376 Globally, 87% of the patients treated with peg-INF responded (26/30), with a CR rate of 70% (21/30). [jhoonline.biomedcentral.com]

  Physical examination may discover conjunctival plethora and ruddy cyanosis; a palpable spleen is found in 40% of cases, whereas massive splenomegaly and hepatomegaly are infrequent. [bloodjournal.org]

• Hepatomegaly

  Nonspecific neurological symptoms : dizziness, headache, visual disturbances, tinnitus Hypertension Splenomegaly : associated with early satiety and abdominal discomfort; less commonly hepatomegaly Peptic ulcer disease Symptoms of thrombotic and hemorrhagic [amboss.com]

  Less common symptoms associated with polycythemia vera include a tendency to bruise easily, frequent nosebleeds or bleeding from the gums, enlargement of the liver (hepatomegaly), and erythromelalgia, a condition characterized by a reddened or purplish [rarediseases.org]

  Hepatomegaly is common, and splenomegaly is present in 75% of cases. One-third of patients is hypertensive. Hypermetabolism can cause low-grade fevers and weight loss and suggests disease progression. Investigations: Raised Hb. Raised red cell mass. [askhematologist.com]

  […] per dL (180 g per L) in white men, 16 g per dL (160 g per L) in blacks and women) Plethora Pruritus after bathing Splenomegaly Weight loss Weakness Sweating Less Common Bruising/epistaxis Budd-Chiari syndrome Erythromelalgia Gout Hemorrhagic events Hepatomegaly [aafp.org]

• Hepatosplenomegaly

  Myelofibrosis can develop in the bone marrow, leading to progressive hepatosplenomegaly. [unboundmedicine.com]

  Physical examination reveals multiple bruises on the bilateral upper and lower extremities and hepatosplenomegaly. Fundoscopic examination demonstrates enlarged retinal veins. Multiple laboratory tests are pending. [step1.medbullets.com]

  Transition of Polycythemia Vera to Chronic Neutrophilic Leukemia Abstract Chronic Neutrophilic Leukemia (CNL) is a rare myeloproliferative disorder characterized by a persistent increase of mature peripheral neutrophils, myeloid hyperplasia in bone marrow, hepatosplenomegaly [kjim.org]

  No lymphadenopathy or hepatosplenomegaly can be palpated. Other systems, including the cardiac, respiratory, and nervous systems, are normal. ERYTHROCYTOSIS AND POLYCYTHEMIA VERA 1. [mdedge.com]

  In some patients, however, the myelofibrosis is accompanied by significant extramedullary hematopoiesis, hepatosplenomegaly, and transfusion-dependent anemia. [theoncologyinstitute.com]

• Headache

  One visible symptom of polycythemia vera are headaches, according to this research from the National Institutes of Health. By reducing blood flow to the brain, painful headaches can become quite common. [activebeat.com]

  Regardless of baseline iron status, treatment with ruxolitinib was associated with improvements in concentration problems, cognitive function, dizziness, fatigue, headaches, and inactivity, although improvements were generally greater among patients with [ncbi.nlm.nih.gov]

  Critical Essential Core Tested Community Questions (3) (M1.ON.4798) A 66-year-old male with a history of diabetes and knee osteoarthritis presents to his primary care provider in July complaining of headaches and blurry vision. [step1.medbullets.com]

• Stroke

  Polycythemia vera (PV) is a risk factor for systemic thromboses and ischemic stroke. This has been attributed to blood hyperviscosity, the result of increased blood cell production. [ncbi.nlm.nih.gov]

  They also cause complications, such as blood clots, which can lead to a heart attack or stroke. Polycythemia vera isn't common. It usually develops slowly, and you might have it for years without knowing. [mayoclinic.org]

• Dizziness

  After treatment, the patient still had left hemiplegia, dizziness and other symptoms and was admitted to our hospital. We did not find sufficient evidence of atherosclerotic processes in the brain infarction. [ncbi.nlm.nih.gov]

  The presenting symptoms are frequently vague and consist of fatigue, headaches, dizziness, bleeding, pruritus, dyspepsia, and thrombosis. [medlink.com]

  Lethargy, confusion, headache, dizziness These symptoms are due to central nervous system disturbances with hyperviscosity causing poor perfusion. [medicaljoyworks.com]

• Paresthesia

  Here we report a case of a 70-year-old man with prior stroke and PV who developed Guillain-Barré syndrome, an acute inflammatory demyelinating disorder of peripheral nerves causing ascending paresis, numbness, and paresthesia, who was treated safely with [ncbi.nlm.nih.gov]

  If thrombotic complications occur in central nervous system, patient will have seizures, paralysis and paresthesia like features. [medicaljoyworks.com]

  Many patients have neurologic symptoms such as headaches, dizziness or vertigo, visual problems, and paresthesias at the time of diagnosis. [medlink.com]

  Weight loss Weakness Sweating Less Common Bruising/epistaxis Budd-Chiari syndrome Erythromelalgia Gout Hemorrhagic events Hepatomegaly Ischemic digits Thrombotic events Transient neurologic complaints (headache, tinnitus, dizziness, blurred vision, paresthesias [aafp.org]

  This may be the initial presentation of PV, and is reported in up to 60% of PV patients under the age of 40], Dizziness - 43%, Diaphoresis - 33%, Visual disturbances - 31%, Weight loss - 29%, Paresthesias - 29%, Dyspnea - 26%, Joint symptoms - 26%, Epigastric [enotes.tripod.com]

• Burning Sensation

  Burning sensation in fingers and toes With the hyperviscosity perfusion becomes poor causing ischemic pains. Burning sensation in fingers and toes With the hyperviscosity perfusion becomes poor causing ischemic pains. [medicaljoyworks.com]

  As the disease progresses, symptoms include: Shortness of breath Dizziness Itchy or flushed skin Fatigue Headaches A tingling or burning sensation in the hands and feet What causes polycythemia vera? PV begins in the bone marrow. [familydoctor.org]

  Low doses of Aspirin will also help relieve the burning sensation on the hands and feet. • Antihistamines – are recommended to reduce and relieve itchiness. • Ultraviolet light treatments – are also recommended to reduce and relieve itchiness and other [pt.slideshare.net]

• Abdominal Pain

  MYTH: The patient's first complaint is usually abdominal pain from an enlarged spleen and liver. [journals.lww.com]

  Case: 58-Year-Old Woman Diagnosed With Polycythemia Vera November 2018 A 58-year old woman presents to PCP complaining of abdominal pain, dizziness and headaches PE: BP 140/85; Splenomegaly 6 cm below left costal margin PMH: No prior history of thrombosis [targetedonc.com]

  As PV progresses, more serious problems can occur, including: bleeding gums bleeding in the digestive tract heavy bleeding from small cuts joint swelling bone pain liver enlargement spleen enlargement blood clots, or thrombosis abdominal pain and fullness [healthline.com]

  Browse recently published Learning/CME Learning/CME View all learning/CME CME Conservative Oxygen Therapy during Mechanical Ventilation in the ICU Case 8-2020: An 89-Year-Old Man with Recurrent Abdominal Pain and Bloody Stools Complications of Unsafe [nejm.org]

  Headaches Blurry vision Red skin on the face, hands, and feet Fatigue High blood pressure Dizziness Abdominal pain Periods of cognitive confusion Gout (inflammation of the joints) Itchy skin Abnormal bleeding and bruising. [news-medical.net]

• Early Satiety

  Early satiety Patients can complain early satiety because splenomegaly causes limitation in gastric stretching by taking extra space from the abdomen. [medicaljoyworks.com]

  It’s fatigue, inactivity, abdominal discomfort, early satiety, fevers, night sweats, weight loss, itching, bone pain, trouble concentrating, and that’s about it. So I would advise proactively asking those questions. Transcript edited for clarity. [targetedonc.com]

  Weight loss may result from early satiety or from the increased myeloproliferative activity of the abnormal clone. [emedicine.medscape.com]

  Nonspecific neurological symptoms : dizziness, headache, visual disturbances, tinnitus Hypertension Splenomegaly : associated with early satiety and abdominal discomfort; less commonly hepatomegaly Peptic ulcer disease Symptoms of thrombotic and hemorrhagic [amboss.com]

  The MPN-SAF TSS asks about worst fatigue, early satiety, abdominal discomfort, inactivity, problems with concentration, night sweats, pruritus, bone pain, fever, and weight loss. Scoring ranged from 0 (none) to 10 (worst imaginable). [ajmc.com]

• Nausea

  Symptoms varied and included cerebral ischemic attacks, mental concentration disturbances followed by throbbing headaches, nausea, vomiting, syncope or even seizures. [ncbi.nlm.nih.gov]

  Epigastric pain/ burning sensation, incresed with meals, nausea, vomiting and regurgitation with or with out blood stained vomitus/ tary colour stools. These patients are at risk of developing peptic ulcers. [medicaljoyworks.com]

  autoimmunity, hyperlipidemia Psychiatric disease, cardiovascular disease Radioactive phosphorus ( 32 P) Radiopharmaceutical Anemia, thrombocytopenia, leukopenia, Leukemia may develop after treatment Diarrhea, fever, nausea, emesis — Busulfan (Myleran [aafp.org]

• Vomiting

  Symptoms varied and included cerebral ischemic attacks, mental concentration disturbances followed by throbbing headaches, nausea, vomiting, syncope or even seizures. [ncbi.nlm.nih.gov]

  Epigastric pain/ burning sensation, incresed with meals, nausea, vomiting and regurgitation with or with out blood stained vomitus/ tary colour stools. These patients are at risk of developing peptic ulcers. [medicaljoyworks.com]

  Tell your healthcare provider if you develop any of the following symptoms of infection: chills, nausea, vomiting, aches, weakness, fever, painful skin rash or blisters. [jakafi.com]

  Other common side effects include fatigue, headache, nausea, vomiting, diarrhea, or fever that seldom cause discontinuation of the drug. [peertechz.com]

  […] aphasia) Sudden blurred, double or decreased vision Sudden dizziness, loss of balance or loss of coordination A sudden, severe headache or an unusual headache, which may or may not be accompanied by a stiff neck, facial pain, pain between your eyes, vomiting [checkorphan.org]

• Loss of Appetite

  Hepatic venous thrombosis will present with abdominal distension(ascites), features of liver insufficiency like nausea, vomiting, loss of appetite, yellowish discoloration of eyes, generalized swelling and gastrointestinal bleeding( either as haemoptysis [medicaljoyworks.com]

  An enlarged spleen may also cause pressure on the stomach causing a feeling of fullness, indigestion and a loss of appetite. In some cases the liver may also be enlarged.This is called hepatomegaly. [leukaemia.org.au]

  Other symptoms may include: extreme tiredness loss of appetite weight loss depression See a GP if you have pain and stiffness for more than a week. They'll try to find out what's causing it. [nhs.uk]

  […] of appetite Unintended weight loss Depression When to see a doctor See your doctor if you have aches, pains or stiffness that: Is new Disrupts your sleep Limits your ability to do your usual activities, such as getting dressed Causes The exact cause [mayoclinic.org]

• Bleeding Gums

  Symptoms include lack of energy (fatigue) or weakness, headaches, dizziness, shortness of breath, visual disturbances, nose bleeds, bleeding gums, heavy menstrual periods, and bruising. [hopkinsmedicine.org]

• Hypertension

  Abstract In a recent International Working Group on Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) study, prior arterial events and hypertension were predictors of subsequent arterial thrombosis whereas prior venous events and age 65 years [ncbi.nlm.nih.gov]

  The major symptoms are related to hypertension or to vascular abnormalities caused by the increased red cell mass. The cause is unknown. With currently available treatment, the median survival exceeds 10 years. [icd9data.com]

  2018 - New Code 2019 Billable/Specific Code Applicable To Group 5 pulmonary hypertension Pulmonary hypertension with unclear multifactorial mechanisms Pulmonary hypertension due to hematologic disorders Pulmonary hypertension due to metabolic disorders [icd10data.com]

• Chest Pain

  If the spleen becomes too enlarged, it can cause discomfort after eating, difficulty breathing, and chest pain. Every year, there are five new cases of PV per 1,000,000 people. [uihc.org]

  Eg; In cardiac complications, patient will present with chest pain, difficulty in bresthing, dizziness, sweating and other features of myocardial infarction/ angina. [medicaljoyworks.com]

  This can lead to angina (chest pain or discomfort) and heart failure. The high levels of red blood cells that PV causes can lead to stomach ulcers, gout, or kidney stones. Some people who have PV may develop myelofibrosis (MY-e-lo-fi-BRO-sis). [hoacny.com]

  (Angina is chest pain or discomfort.) Overview Red blood cells carry oxygen to all parts of your body. They also remove carbon dioxide (a waste product) from your body’s cells and carry it to the lungs to be exhaled. [oncologynurseadvisor.com]

  Stop if you feel any chest pain or shortness of breath. Drink liquids as directed. Liquids help keep your blood thin. Your healthcare provider may recommend that you drink at least 3 liters (12 cups) of liquid each day. [drugs.com]

• Cyanosis

  ER-ih-THRE-me-ah) Erythrocytosis (eh-RITH-ro-si-TO-sis) megalosplenica (MEG-ah-lo-SPLE-ne-kah) Myelopathic (MY-e-lo-PATH-ik) polycythemia Myeloproliferative (MY-e-lo-pro-LIF-er-ah-tiv) disorder Osler disease Polycythemia rubra vera Polycythemia with chronic cyanosis [hoacny.com]

  This causes a blue coloration of the skin (cyanosis). [aoporphan.com]

  Primary polycythemia; Polycythemia rubra vera; Myeloproliferative disorder; Erythremia; Splenomegalic polycythemia; Vaquez's disease; Osler's disease; Polycythemia with chronic cyanosis; Erythrocytosis megalosplenica; Cryptogenic polycythemia Kremyanskaya [medlineplus.gov]

• Tinnitus

  Some people with polycythemia vera have headache, dizziness, tinnitus (tinnitus), impaired vision, or itchy skin. Other complications of polycythemia vera include splenomegaly, stomach ulcers, gout, heart disease and leukemia. [ivami.com]

  Polycythemia Vera Signs and symptoms Symptoms related to expanded blood volume and increased viscosity Headache, tinnitus, dizziness, blurred vision, TIAs, and fatigue Generalized pruritus (aquagenic) Engorged retinal veins Palpable spleen (75%) Thrombosis [slideshare.net]

  Difficulty breathing when lying down Enlarged (bigger than normal) spleen (organ that clears blood cells from the body) Blurry or double vision Itchy skin, especially following a warm bath Skin that is reddish or purplish in color Bleeding gums Weight loss Tinnitus [my.clevelandclinic.org]

  Headache, dizziness, tinnitus, blurred vision, and fatigue are common complaints related to expanded blood volume and increased blood viscosity. [accessmedicine.mhmedical.com]

  Other symptoms may include: Itching all over the body ( especially when showering or bathing - aquagenic pruritus) Hypertension Headache Dizziness Painful blood microcirculation disorder of the hand and feet Ringing in the ear (tinnitus) Nose bleeds Visual [aoporphan.com]

• Blurred Vision

  MIAs were frequently preceded or followed by ocular ischemic events of blurred vision, scotomas, transient flashing of the eyes, and sudden transient partial blindness preceded or followed erythromelalgia in the toes or fingers. [ncbi.nlm.nih.gov]

  Polycythemia Vera Signs and symptoms Symptoms related to expanded blood volume and increased viscosity Headache, tinnitus, dizziness, blurred vision, TIAs, and fatigue Generalized pruritus (aquagenic) Engorged retinal veins Palpable spleen (75%) Thrombosis [slideshare.net]

  Others might have: Itchiness, especially following a warm bath or shower Headache Dizziness Bleeding or bruising, usually minor Weakness Fatigue Blurred vision Excessive sweating Painful swelling of one joint, often the big toe Shortness of breath Numbness [mayoclinic.org]

  The most common symptoms of polycythemia vera are fatigue, dizziness, increased sweating, redness in the face, blurred vision, and itchy skin especially after a hot shower. [osmosis.org]

  […] and symptoms of PV include: Headaches, dizziness, and weakness Shortness of breath and problems breathing while lying down Feelings of pressure or fullness on the left side of the abdomen due to an enlarged spleen (an organ in the abdomen) Double or blurred [hoacny.com]

• Visual Impairment

  impairment Possible complications The most common complications are a result of the high viscosity (resistance to flow) of the blood, which can lead to blood clots (thrombosis). [aoporphan.com]

  Presenting non-specific symptoms of polycythemia vera are related to hypoxia and include: Headache Dizziness Visual impairment Tinnitus Angina pectoris The signs and symptoms found in individuals diagnosed with polycythemia vera include: Elevated red [symptoma.com]

• Pruritus

  Abstract Aquagenic pruritus is one of the main clinical features of polycythemia vera. The aim of this study was to analyse the clinical characteristics of aquagenic pruritus. [ncbi.nlm.nih.gov]

  Christelle Le Gall-Ianotto and Laurent Misery, Pruritus in Hematological Diseases (Including Aquagenic Pruritus), Pruritus, 10.1007/978-3-319-33142-3_36, (271-281), (2016). [doi.org]

• Flushing

  Clinical features include facial flushing, pruritus, erythromelalgia, headaches, and dizziness. Severe complications such as thrombotic events (e.g., stroke, Budd-Chiari syndrome) may occur. [amboss.com]

  Symptoms of Polycythemia Vera Frequent headaches and a feeling of pressure in the head Dizziness and ringing in the ears (tinnitus) Fatigue Blurred or double vision Flushed or itching skin Night sweats Shortness of breath Itchy or flushed skin Frequent [healthcommunities.com]

  As the disease progresses, symptoms include: Shortness of breath Dizziness Itchy or flushed skin Fatigue Headaches A tingling or burning sensation in the hands and feet What causes polycythemia vera? PV begins in the bone marrow. [familydoctor.org]

  Symptoms Symptoms of PV may include: Fatigue and/or weakness Headache Dizziness Shortness of breath and difficulty breathing while lying down Visual disturbance, such as double vision, blurred vision, and blind spots Inability to concentrate Night sweats Flushed [hopkinsmedicine.org]

• Erythema

  Erythema, burning, and pain in the extremities, a symptom complex known as erythromelalgia, is another complication of the thrombocytosis of PV. [theoncologyinstitute.com]

  […] age of 40], Dizziness - 43%, Diaphoresis - 33%, Visual disturbances - 31%, Weight loss - 29%, Paresthesias - 29%, Dyspnea - 26%, Joint symptoms - 26%, Epigastric discomfort - 24% Physical Findings Splenomegaly -70%; Hepatomegaly- 40%, Skin plethora/erythema [enotes.tripod.com]

  The symptoms are burning pain in the feet, hands, toes and fingers, sometimes associated with pallor, erythema, or cyanosis. Occasionally, it progresses to gangrene. [symptoma.com]

  […] stinging sensation that occurs in 30 minutes of contact with water, without any skin changes (Int J Dermatol 2018 Dec 2 early online) erythromelalgia - neurovascular pain syndrome characterized by periodic attacks with triad of increased temperature, erythema [dynamed.com]

  […] present in 30% to 50% of PV patients. 14 Symptoms more specific to PV include: Pruritus, especially after warm baths or showers (aquagenic pruritus; reported by 70% of patients) 15 Erythromelalgia, or a burning pain in the feet or hands accompanied by erythema [mpncanada.com]

• Increased Sweating

  The most common symptoms of polycythemia vera are fatigue, dizziness, increased sweating, redness in the face, blurred vision, and itchy skin especially after a hot shower. [osmosis.org]

• Urticaria

  Soter, Acute and chronic urticaria and angioedema, Journal of the American Academy of Dermatology, 25, 1, (146), (1991). JULIA A. NEWTON, A.K. SINGH, M.W. GREAVES and C.J.F. [doi.org]

• Bone Pain

  Symptoms may include: Abnormal and heavy bleeding due to a cut or a nosebleed Intense and frequent bone pain and/or muscle pain Headaches, lightheadedness or gastrointestinal symptoms Vision problems Ringing in the ears Difficulty or labored breathing [cancer.uvahealth.com]

  Treatments for Symptoms Aspirin can relieve bone pain and burning feelings in your hands or feet that you may have as a result of PV. Aspirin also thins your blood, so it reduces the risk of blood clots. [nhlbi.nih.gov]

  It’s fatigue, inactivity, abdominal discomfort, early satiety, fevers, night sweats, weight loss, itching, bone pain, trouble concentrating, and that’s about it. So I would advise proactively asking those questions. Transcript edited for clarity. [targetedonc.com]

  pain Gout attacks Shortness of breath Weakness Bruising excessively Numbness or tingling in feet Prevention PV cannot be prevented. [texasoncology.com]

• Arthralgia

  […] during investigation of vague upsets, such as unexplained weakness, pruritus (typically after a shower with warm water, but eventually during physical exercise, at bed time, or when changing cloths), headache, paresthesia, tinnitus, blurred vision, arthralgia [bloodjournal.org]

• Joint Swelling

  As PV progresses, more serious problems can occur, including: bleeding gums bleeding in the digestive tract heavy bleeding from small cuts joint swelling bone pain liver enlargement spleen enlargement blood clots, or thrombosis abdominal pain and fullness [healthline.com]

  swelling You may also feel pressure or fullness below your ribs on your left side. [webmd.com]

• Epistaxis

  Epistaxis is probably related to engorgement of mucosal blood vessels in combination with abnormal hemostasis. Sixty percent of patients are men, and the median age at presentation is 60 years. [accessmedicine.mhmedical.com]

  Thrombotic complications Venous thrombosis Arterial thrombosis Hemorrhagic complications Petechiae Epistaxis Bleeding gums References:[2][4][10][16] We list the most important complications. The selection is not exhaustive. [amboss.com]

  Bleeding complications occur in 1% of patients with polycythemia vera and include epistaxis, gum bleeding, ecchymoses, and gastrointestinal bleeding. [symptoma.com]

  […] white men, 47 percent (0.47) in blacks and women Hemoglobin level 18 g per dL (180 g per L) in white men, 16 g per dL (160 g per L) in blacks and women) Plethora Pruritus after bathing Splenomegaly Weight loss Weakness Sweating Less Common Bruising/epistaxis [aafp.org]

  […] thrombosis lead to poor oxygen delivery, with symptoms that include the following: Headache Dizziness Vertigo Tinnitus Visual disturbances Angina pectoris Intermittent claudication Bleeding complications, seen in approximately 1% of patients with PV, include epistaxis [emedicine.medscape.com]

The presence of the Janus kinase-2 (JAK2 V617F) mutation is diagnostic for polycythemia vera [4] [5] [12]. However, 2-3% of patients are negative for this genetic marker [12] [13]. The absence of the Janus kinase-2 mutation combined with a normal or increased serum erythropoietin level, excludes the diagnosis [9]. These patients have secondary erythrocytosis rather than polycythemia vera [5] [12].

Diagnostic criteria for polycythemia vera according to the World Health Organization guidelines require the presence of both major criteria and one minor criterion or the presence of the first major criterion together with two minor criteria [12] [14].

Major criteria [10] [12] [13]:

• Elevated red cell mass >25% or Hemoglobin > 18.5 g/dL (Hematocrit >60) in men and > 16.5 g/dL (Hematocrit >56) in women
• Presence of Janus kinase-2 mutation

Minor criteria [10] [12] [13]:

• Palpable splenomegaly
• Decreased serum erythropoietin level 
• Bone marrow biopsy showing erythroid, granulocytic, and megakaryocytic proliferation 
• Endogenous erythroid colony formation in vitro

Laboratory studies suggested for evaluation of polycythemia vera [2] [4] [12] [13]:

• Janus kinase-2 mutation analysis
• Direct measurement of the red blood cell mass is often not possible
• Complete blood count: Red blood cell counts with hematocrit and hemoglobin levels, Red blood cells are generally normochromic and normocytic, White blood cell count (>12,000/µL) primarily neutrophils with a left shift, Platelet count is elevated to 400,000-800,000/µL

• Serum erythropoietin level 
• Erythroid progenitor cell assay
• Leukocyte alkaline phosphatase (LAP) is elevated (>100 U/L)
• Routine coagulation tests are usually normal, 
• Vitamin B-12 levels elevated to > 900 /mL
• Oxygen saturation (SaO2) and carboxyhemoglobin (COHb) levels
• Iron studies

Imaging 

An enlarged spleen is often palpable and in such cases, imaging studies are not required [12] [13]. Ultrasonography or computed tomography scans may be able to detect splenic enlargement that was not evident on physical examination [12].

The diagnosis of Budd-Chiari syndrome is made using ultrasonography, computed tomography scan and magnetic resonance imaging [18].

Other tests

Bone marrow studies are not necessary to establish the diagnosis of polycythemia vera [2] [4]. They are important in identifying transformation to acute leukemia [4] [5]. Patients should be followed monthly until normalization of blood cell counts and splenomegaly, then every 2 months for complete blood count and blood smear evaluation [5].

• Plasma Volume Increased

  Review Topic QID: 109194 1 Increased plasma volume, increased RBC mass, decreased EPO, normal SaO2 2 Normal plasma volume, increased RBC mass, increased EPO, normal SaO2 3 Decreased plasma volume, normal RBC mass, normal EPO, normal SaO2 4 Normal plasma [step1.medbullets.com]

• Erythrocytosis

  Unexpectedly, the symptom of erythrocytosis disappeared after the surgery. Further examination and analysis were performed, and we finally attributed his erythrocytosis to chromophobe renal cell carcinoma. [ncbi.nlm.nih.gov]

  Increased production confined to the RBC line is termed erythrocytosis; isolated erythrocytosis may occur with polycythemia vera but is more commonly due to other causes (see secondary erythrocytosis ). [merck.com]

  The survey focused on 3 aspects of PV care: diagnosis, treatment of erythrocytosis, and treatment of thrombocytosis. [doi.org]

• Thrombocytosis

  Therapy for thrombocytosis in polycythemia vera Considerably less uniformity was noted among physicians regarding treatment of thrombocytosis. [doi.org]

  Hydroxyurea (62.8%) and anagrelide (35.4%) were the primary agents used to treat thrombocytosis. [ncbi.nlm.nih.gov]

  thrombocytosis or isolated leukocytosis, or any combination of these. [jhu.pure.elsevier.com]

• Vitamin B12 Increased

  Polycythemia Vera Laboratory findings Elevated Hct – often 60% Increased WBCs and platelets Serum EPO levels are low Decreased iron stores (Ferritin) Increased Vitamin B12 Increased uric acid Presence of the JAK2 mutation Hypercellular bone marrow 5. [slideshare.net]

• Leukocyte Alkaline Phosphatase Increased

  alkaline phosphatase, increased vit.B12 level, decreased folic acid level, elevated alk.phosphatase & conjungated bilirubin, hypercalcemia. [enotes.tripod.com]

• Hyperglobulinemia

  Chronic polycythemia caused by a genetic mutation affecting hematopoietic stem cells, characterized by increased blood volume, bone marrow hyperplasia, redness of the skin, and splenic enlargement. polycythemia vera polycythemia vera Hyperglobulinemia [medical-dictionary.thefreedictionary.com]

• Hypercellular Bone Marrow

  Polycythemia Vera Laboratory findings Elevated Hct – often 60% Increased WBCs and platelets Serum EPO levels are low Decreased iron stores (Ferritin) Increased Vitamin B12 Increased uric acid Presence of the JAK2 mutation Hypercellular bone marrow 5. [slideshare.net]

  bone marrow with panmyelosis Erythroid hyperplasia often predominates Low serum erythropoietin (EPO) Endogenous erythroid colony formation in vitro Variable excess platelet or leukocyte production Post-polycythemic myelofibrosis phase requires both: [surgpathcriteria.stanford.edu]

  bone marrow with trilineage growth, and (3) presence of a JAK2 mutation; minor criteria: hypercellular bone marrow with trilineage growth, low serum erythropoietin levels, and endogenous erythroid colony formation). [hindawi.com]

  Figure A: Hypercellular bone marrow Figure B: Panmyelosis Figure C: Mild increase in reticulin fibers Figure D: Leukoery-throblastosis Figure E: Fibrosis and erythroid islands Figure F: Core biopsy with dense fibrosis Figure G: Core biopsy with extensive [pathologyoutlines.com]

• Bone Marrow with Hyperplasia

  marrow erythroid hyperplasia, increased leukocyte alkaline phosphatase, increased vit.B12 level, decreased folic acid level, elevated alk.phosphatase & conjungated bilirubin, hypercalcemia. [enotes.tripod.com]

• Bone Marrow with Erythroid Hyperplasia

  Marrow Biopsy: Erythroid hyperplasia Cytogenetics: JAK-V617F mutation [targetedonc.com]

The goal of treatment for polycythemia vera is to control myeloproliferation [10] [15] and decrease the risk of arterial and venous thrombotic events, which occur in approximately 20% of patients [2] [9]. The optimum management plan is unclear. Significant differences exist among physicians about the appropriate management of the disease [2]. Consultation with and management by a hematologist is recommended [5].

General guidelines for the management of polycythemia vera include [2] [5] [9] [15]:

• Maintain a hematocrit of 44% or less is the target
• Minimize the risk of transformation to acute leukemia and myelofibrosis
• Manage complications such as thrombosis and hemorrhage

Medical management:

• Phlebotomy alone is the first choice
• A combination of phlebotomy and hydroxyurea
• Hydroxyurea alone, (interferon, 32P or busulfan are used infrequently)
• Low-dose aspirin
• Treatment of thrombocytosis recommended for platelet counts above 400,000

All patients with polycythemia vera require phlebotomy to keep their hematocrit levels below 44% [5] [15]. This treatment removes excess red blood cells and lowers blood viscosity [10]. Patients can be phlebotomized once or twice a week [5] [10]. Elderly patients with cardiovascular or cerebral vascular conditions should have volume replaced with saline solution after each procedure to avoid postural hypotension [10]. Chemotherapy and phlebotomy can decrease the risk for thrombotic events [11].

Patients with this disorder should routinely take low-dose aspirin, 81 mg daily [5]. Low-dose aspirin suppresses thromboxane biosynthesis resulting from increased platelets and essential thrombocythemia [5] [11]. Treatment with aspirin may also reduce the risk of myocardial infarction, stroke, or death from cardiovascular causes, pulmonary embolism, or major venous thrombosis [10] [11]. The incidence of major bleeding episodes was not significantly increased with aspirin [11].

Patient at high risk for thrombosis should have drug therapy to decrease blood cell production. Hydroxyurea at a starting dose of 500 mg twice daily is the most commonly used agent. It is an effective agent for myelosuppression [5]. It reduced the risk of thrombosis when compared with phlebotomy [5]. It should be the drug of choice for patients older than 40 years [6]. However, there are concerns that it may increase the long-term risks of leukemic transformation [6]. 

Interferon-alpha can be used as an alternative [9] [10]. Studies have shown that treatment with this drug was not as effective when compared with hydroxyurea. However, interferon alfa 2b had a lower transformation rate and no severe hematological adverse effects [8].

Busulfan is also an option for patients older than 65 years of age who do not respond to hydroxyurea [10].

Ruxolitinib (Jakafi), a Janus-associated kinase inhibitor, is the first US Food and Drug Administration drug approved specifically for polycythemia vera [1]. It is approved for use in patients with polycythemia vera who cannot tolerate or had an inadequate response to hydroxyurea [1]. Patients who received ruxolitinib had a significant reduction in splenomegaly [12] [13].

Once the patient's red blood cell values are reduced periodic phlebotomies or a myelosuppressive agent should be continued to maintain disease control [5] [10].

Splenectomy should be only considered in patients with painful splenomegaly or splenic infarction [10] [11]. Treatment of Budd-Chiari syndrome includes portal or mesenteric-systemic shunting, catheter-directed thrombolysis, and liver transplantation [18].

Untreated polycythemia has a very poor prognosis. The median survival in untreated patients is 1.5-3 years. Treated this may be extended to at least 10-20 years [1]. Thrombosis is the leading cause of death [10]. Thrombotic complications including stroke and other arterial thromboses occur in ~1% of patients. The risk of thrombosis depends on age of the patient and their past history of thrombosis. Patients older than 60 years or with a previous history of thrombosis are considered at high risk [1] [10].

Bleeding complications occur in ~ 1% of patients with polycythemia vera and include epistaxis, gum bleeding, ecchymoses, and gastrointestinal bleeding [8].

The long-term risks of polycythemia vera include leukemic and fibrotic transformation occurring in 5-10% of patients [8] [9] [15]. Studies have suggested an increased risk for all neoplasms with the use of chemotherapic agents in polycythemia vera.

Vaquez is credited with the initial description of polycythemia vera in 1892. The clinical features were first described by Osler in 1903 [2]. In 1967, the Polycythemia Vera Study Group identified criteria for diagnosis and treatment of the disease [2] [5].

The etiology of all the myeloproliferative disorders is unknown [3]. The cause of the symptoms of polycythemia vera is an uncontrolled blood cell proliferation [4] [12] [13]. The abnormal cell production is a mutation in the Janus kinase-2 gene [13]. The cause if this mutation is unknown. Virtually all patients with polycythemia vera have the mutation. The discovery of the Janus kinase-2 gene mutation has improved the diagnosis of polycythemia vera [13].

The mean age of incidence of polycythemia vera is 50-70 years [8], but it can occur in all age groups, although rarely in childhood [7] [14]. Familial cases are very rare usually in elderly family members [7].

The severity of polycythemia vera and the rate of progression vary from patient to patient [8]. All myeloproliferative disorders, including polycythemia vera, are pre-leukemic as they can transform to acute leukemia over time. The rate of leukemic transformation in polycythemia vera is 5-10% of patients [8] [15].

Polycythemia vera is relatively rare, affecting in 0.6-1.6/million population [10]. The disorder can occur at any age, but it has a median age at onset of 60 years [10]. Studies have shown that this condition concerns all ethnic groups [1]. Polycythemia vera occurs almost equally in both sexes [12], though a few studies have found that slightly more males than females are affected [2].

Myeloproliferative disorders like polycythemia vera are hematopoietic stem cell malignancies [3] [8]. Abnormal stem cells present in the bone marrow of patients with polycythemia vera suppress normal stem cell maturation [12].

These abnormal blood stem cells respond aberrantly to growth factors [4]. A mutation on the Janus kinase-2 gene (JAK2) is the most likely gene involved in polycythemia vera [4] [6] [12]. It is thought that the defect alters the signal from growth enzymes to the stem cells [12]. Polycythemia vera stem cells are hypersensitive to erythropoietin and hematopoietic growth factors [8]. This mutation occurs in most (> 80%) polycythemia vera patients [6]. The mutation leads to tyrosine phosphorylation activation that causes cytokine hypersensitivity that induces erythrocytosis [6] [8].

Serum levels of erythropoietin are normal or subnormal in polycythemia vera patients, therefore the hyperproliferation is not stimulated extrinsically and the disease is classified as a primary polycythemia [8].

In polycythemia vera excessive red blood cells are produced in the bone marrow [1]. Patients may also experience an increase in white blood cells and platelets [1]. These blood cells show no cytogenetic abnormality, all blood cells produced are normal [8]. The overabundance of blood cells causes splenomegaly, bleeding problems, and thrombosis [1] [14]. Studies have shown that hematocrits above 44 are associated with an increased number of thromboembolic events [2].

Thrombotic events in polycythemia vera are the result of the increased viscosity of the blood due to the excessive numbers of blood cells. Increased thromboxane synthesis occurs as well due to thromboxane-dependent platelet activation [11]. This is a major cause of the increased risk of thrombosis. Low-dose aspirin suppresses the production of thromboxane by platelets in patients with high platelet counts and [11].

A paradoxical bleeding or hemorrhagic tendency occurs with high platelet counts that resembles acquired Von Willebrand disease in patients with polycythemia vera[16].

As in all the myleoproliferative disorders, polycythemia vera may progress to blood malignancies such as acute leukemia and myleofibrosis [9]. Transformation rates are estimated to be 10-20% [9] [10]. Leukemic transformation of polycythemia vera can be influenced by pharmacotherapy such as alkylating agents [10]. Acute leukemia is thought to be a part of the natural course of polycythemia vera [11].

Budd–Chiari syndrome, obstruction and occlusion of the suprahepatic veins, is a rare life-threatening complication in polycythemia vera [7]. It is the result of thrombosis within the vasculature of the liver[18].

Differential diagnoses for polycythemia vera include [7] [9]:

• Chronic myeloid leukemia (CML)
• Agnogenic myeloid metaplasia (AMM)
• Fibrotic myelofibrosis
• Conditions causing systemic hypoxia
• Conditions stimulating erythropoietin secretion
• Infections or leukemoid reactions
• Thrombocytosis from bleeding
• Iron deficiency
• Essential thrombocytosis

A cause for the development of the Janus kinase-2 genetic mutation is unknown, therefore there is no way to prevent its occurrence.

Phlebotomy, myelosuppressive drugs, and anticoagulants can prevent thrombosis, stroke, liver and renal damage, and other cardiovascular events [10] [11]. Studies have shown that low dose aspirin (81 mg/d) is effective for preventing thrombosis without causing bleeding [11].

Polycythemia vera is a chronic myeloproliferative stem cell disorder [1] [2]. It is one of several acquired myeloproliferative diseases that are considered malignant bone marrow disorders [1] [3] [4]. Polycythemia vera and the other myeloproliferative diseases are relatively uncommon [5].

The primary characteristic of polycythemia vera is an elevated absolute red blood cell count due to uncontrolled red blood cell production [2]. Panmyelosis may also be seen as increased white blood cell and platelet production [1] [2]. Other characteristic features of polycythemia vera are splenomegaly, a predisposition to venous/arterial thrombosis, and bleeding [6]. It can eventually progress to myelofibrosis, and acute leukemia [2].

Polycythemia vera arises from acquired mutations in a hematopoietic stem cell [7] [8]. The mechanisms accounting for the development of these mutations are poorly understood [8]. The genetic mutations of polycythemia vera usually occurs sporadically, but occasional familial cases have been reported [7]. The median age at diagnosis of polycythemia vera is 60 years of age [11]. It is a progressive disease and approximately 5% of patients progress to acute leukemia [9] [10].

The rise in red blood cell load in polycythemia vera results in hyperviscosity of the blood and subsequent circulatory disturbances. The primary cause of death is acute cardiovascular or cerebrovascular events [11].

What is polycythemia vera ?

Polycythemia vera is a chronic disease of blood cell producing stem cells of the bone marrow. The overproduction of red blood cells, primarily, white blood cells and platelets occur because of a genetic mutation of these stem cells. The median age at diagnosis is 60 years of age. Although disease itself is not fatal, death will occur within 1 ½ to 3 years from cardiovascular complications of blood clot formation.

What are the symptoms?

Polycythemia vera is often asymptomatic at first. It may initially present with non-specific symptoms of decreased oxygen supply such as: headache, dizziness, vertigo, and angina. Other individuals will not be diagnosed until they experience a major blood clotting event.

The clinical signs of the disorder are:

• Elevated red blood cell count; hematocrit over 60
• Elevated white blood cell and platelet count
• Enlarged spleen
• Tendency for abnormal clotting

What causes polycythemia vera?

The cause is a mutation of the Janus Kinase-2 gene that is responsible for the regulation of blood cell production. Because of this mutation blood cell production is excessive. The extreme number of circulating blood cells causes the blood to be more viscous increasing the risk of blood clot formation.

Who gets polycythemia vera?

Polycythemia vera can occur at any age, however it is rare in individuals younger than 40 years of age. Mean age at onset is 60 years.

How is it diagnosed?

The definitive diagnosis of polycythemia vera is made when the Janus Kinase-2 gene mutation is detected. Routine blood tests will show an excessive increase in red blood cells, white blood cells, and platelets.

How is polycythemia vera treated?

Polycythemia vera is treated primarily with periodic phlebotomy, blood-letting, to remove excessive blood cells and reduce blood viscosity. Myelosupressive medications, such as Hydroxyurea, reduce blood cell production. All patients are also given low-dose aspirin to prevent clotting.

What are the complications?

The complications of polycythemia vera are due to abnormal clotting and include:

• Stroke
• Pulmonary emboli
• Myocardial infarct
• Circulatory compromise in the extremities
• Obstructive liver disease
• Obstructive renal damage

How can it be prevented?

Since a cause of the Janus kinase-2 genetic mutation is unknown, there is no way to prevent polycythemia vera. Phlebotomy, myelosuppressive drugs, and anticoagulants can prevent the complications of the disease and extend life expectancy.

1. Berlin NI. Diagnosis and classification of the polycythemias. Semin Hematol. 1975;12(4):339-51.
2. Streiff MB, Smith B, Spivak JL. The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns. Blood. 2002;99(4):1144-9.
3. James C, Ugo V, Le Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434(7037):1144-8.
4. Vannucchi AM, Guglielmelli P, Tefferi A. Advances in Understanding and Management of Myeloproliferative Neoplasms. Cancer J Clin. 2009;59:171-191.
5. Passamonti F. How to manage polycythemia vera. Leukemia. 2012; 26(5):870-4.
6. Weinfeld A, Swolin B, Westin J. Acute leukaemia after hydroxyurea therapy in polycythaemia vera and allied disorders: prospective study of efficacy and leukaemogenicity with therapeutic implications. Eur J Haematol. 1994;52(3):134-9.
7. Cario H, Pahl HL, Schwarz K, et al. Familial polycythemia vera with Budd–Chiari syndrome in childhood. British Journal of Haematology, 2003, 123, 346–352.
8. Pahl HL. Towards a molecular understanding of polycythemia rubra vera. Eur. J. Biochem. 2000;267, 3395-3401.
9. Tefferi A. Polycythemia vera and essential thrombocythemia: 2012 update on diagnosis, risk-stratificati on. American Journal of Hematology. 2012; 87:285 293.
10. McMullin MF, Bareford D, Campbell P, et al. Guidelines for the diagnosis, investigation and management of polycythaemia/ erythrocytosis. British Journal of Haematology. 2005;, 130, 174–195.
11. Landolfi R, Marchioli R, Kutti J, et al. Efficacy and safety of low-dose aspirin in polycythemia vera. N Engl J Med. 2004;350(2):114-24.
12. Kralovics R, Teo SS, Buser AS, et al. Altered gene expression in myeloproliferative disorders correlates with activation of signaling by the V617F mutation of Jak2. Blood. 2005;106(10):3374-6.
13. Guglielmelli P, Barosi G, Pieri L, Antonioli E, Bosi A, Vannucchi AM. JAK2V617F mutational status and allele burden have little influence on clinical phenotype and prognosis in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis. Haematologica. 2009;94(1):144-6.
14. Berk PD, Goldberg JD, Donovan PB, Fruchtman SM, Berlin NI, Wasserman LR. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols. Semin Hematol. 1986;23(2):132-43.
15. Marchioli R, Finazzi G, Specchia G, et al. Cardiovascular events and intensity of treatment in polycythemia vera. New Eng J Med. 2013;368(1):22-33.